PHAT Market Cap & Key Metrics
Phathom Pharmaceuticals, Inc.
$7.52
+$0.12(+1.62%)
34
Overall
40
Value
18
Tech
44
Quality
Market Cap
$598.67M
Volume
371.29K
52W Range
$6.52 - $18.31
Target Price
$20.45
PHAT market cap is $598.67M. This page lists Phathom Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
PHAT Key Metrics
- Market cap
- $598.67M
- EPS estimate, current year
- $-0.27
- EPS growth, 3-year
- +15.66%
- Value score
- 40
- Quality score
- 44
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $175.11M | $55.25M | $682.0K | - | - |
| EBITDA | -$149.49M | -$259.33M | -$203.45M | -$169.80M | -$136.57M |
| EPS | $-3.03 | $-5.29 | $-3.93 | $-5.05 | $-3.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHAT | $7.52 | +1.6% | 371.29K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phathom Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW